Mechanistically, studies suggest that SP140 promotes PD-L1 expression through STAT1/IRF1 activation in tumor-associated macrophages, which may explain its association with immune escape and poor prognosis in cancers such as glioma and ccRCC. Here, IRF1 is linked to nonpapillary renal cell carcinoma.